# Immune Effects of Low-dose Naltrexone in ME/CFS

> **NCT02965768** · NA · WITHDRAWN · sponsor: **University of Alabama at Birmingham**

## Conditions studied

- Fatigue Syndrome, Chronic

## Interventions

- **DRUG:** Naltrexone HCl

## Key facts

- **NCT ID:** NCT02965768
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-01
- **Primary completion:** 2022-08-25
- **Final completion:** 2022-08-25
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was temporarily suspended to focus on other projects, but was never resumed. No participants were determined eligible and none started the protocol.
- **Last updated:** 2022-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02965768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02965768, "Immune Effects of Low-dose Naltrexone in ME/CFS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02965768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*